$1.30
+3.17%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$1.27
From 52W high−77.47%
Volume661627.00
Market cap$150.80M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataOct 19, 2026
Open
$1.27
From 52W high
−77.47%
Volume
661627.00
Market cap
$150.80M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.6x
P/E (TTM)
—
RSI (14)
35.5
MomentumView details →
1D Return
+3.17%
YTD Return
−67.09%
Similar companies
Latest newsMore news →
NovaBridge Biosciences granted NovaBridge Biosciences exclusive rights to develop and commercialize HT006.2.2 worldwide except in Greater China.7d agoNovaBridge Biosciences reported financial results for the six months ended June 30, 2026, and provided a business update on pipeline momentum and strategic execution.61d ago